Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
  • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
  • A61J7/0015—Devices specially adapted for taking medicines
  • A61J7/003—Sticks, e.g. lollipops with drug release
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
  • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
  • B65D83/00—Containers or packages with special means for dispensing contents
  • B65D83/04—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, spherical or like small articles, e.g. tablets or pills
  • B65D83/0409—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, spherical or like small articles, e.g. tablets or pills the dispensing means being adapted for delivering one article, or a single dose, upon each actuation
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
  • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
  • A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
  • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
  • A61J7/0015—Devices specially adapted for taking medicines
  • A61J7/0053—Syringes, pipettes or oral dispensers
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
  • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
  • A61K31/445—Non condensed piperidines, e.g. piperocaine
  • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
  • A61K31/47—Quinolines; Isoquinolines
  • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
  • A61P25/04—Centrally acting analgesics, e.g. opioids
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
  • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
  • A61M31/007—Injectors for solid bodies, e.g. suppositories

Definitions

• the present invention relates to a child resistant safety cover for an oral dosage form, particularly an oral dosage form that is equipped with a holder or a handle.
• a child resistant safety device for an oral dosage form comprising a medicinal agent.
• the safety device includes a handle having a proximal end and a distal end to which an oral dosage form is mounted either directly or indirectly; and a cover that moves with respect to the handle, or vice versa, for selectively shielding the oral dosage form.
• the cover and/or the handle is/are biased toward a retracted position in which the cover conceals the oral dosage form to limit access to the oral dosage form, and, the cover and/or the handle is/are moveable to a deployed position in which the oral dosage form is accessible to the user.
• a retractable oral dosage form includes an oral dosage form comprising a medicinal agent; a safety device including a handle to which the oral dosage form is attached either directly or indirectly; and a cover associated with the handle for selectively shielding the oral dosage form.
• the oral dosage form In a retracted configuration of the safety device, the oral dosage form is shielded by the cover to limit access to the oral dosage form, and, in a deployed position of the cover, the oral dosage form is accessible to the user.
• the retractable oral dosage form also includes a releasable locking mechanism that is moveable between a locked configuration and an unlocked configuration. In the locked configuration, the releasable locking mechanism is configured to prevent movement of the safety device to the deployed configuration, and, in the unlocked configuration, the releasable locking mechanism is configured to permit movement of the safety device to the deployed configuration.
• a child resistant safety device for an oral dosage form comprising a medicinal agent.
• the safety device includes a handle having a proximal end for grasping by a user and a distal end to which an oral dosage form is mounted either directly or indirectly; and a cover associated with the handle for shielding the oral dosage form.
• the oral dosage form In a retracted configuration of the safety device, the oral dosage form is shielded by the cover to prevent access thereto, and, in a deployed configuration of the safety device, the oral dosage form is accessible to the user.
• the cover and/or the handle is/are biased toward the retracted configuration.
• the safety device also includes a releasable locking mechanism for preventing movement of the safety device from the retracted configuration to the deployed configuration.
• the position (or configuration) of the device or retractable oral dosage form which is referred to herein as a "retracted position” (or “retracted configuration”) corresponds to a “retracted/locked position,” (or “retracted/locked configuration”), wherein a releasable locking mechanism prevents movement to the deployed position until and unless the locking mechanism is released.
• FIG. 1 A depicts a perspective view of a safety device for an oral dosage form according to a first exemplary embodiment of the invention, wherein the safety device is shown in a retracted configuration whereby the oral dosage form is shielded by a child resistant cover.
• FIG. IB depicts a perspective view of the safety device of FIG. 1A shown in a deployed configuration whereby the oral dosage form is exposed.
• FIG. 2 depicts an exploded view of the safety device of FIGs. 1A and IB.
• FIG. 5 depicts a cross-sectional side elevation view of the retracted safety device of FIG. 3 taken along the lines 5-5.
• FIG. 6 depicts a cross-sectional side elevation view of the retracted safety device of FIG. 4 taken along the lines 6-6.
• FIGs. 7A and 7B depict front elevation and cross-sectional views, respectively, of the safety device of FIG. 6 with the tabs of the child resistant cover shown in a depressed position.
• FIGs. 8A and 8B depict elevation and cross-sectional views, respectively, of the safety device of FIGs. 7A and 7B with the tabs of the child resistant cover shown depressed and the child resistant cover slid in a proximal direction.
• FIGs. 9A and 9B depict elevation and cross-sectional views, respectively, of the safety device of FIGs. 8 A and 8B with the tabs of the child resistant cover depressed and the child resistant cover slid further in the proximal direction such that the oral dosage form is exposed.
• FIGs. 10 and 11 depict perspective and side elevation views, respectively, of the child resistant cover of the safety device of FIGs. 1-9.
• FIG. 12 depicts a cross-sectional side elevation view of the child resistant cover of FIG. 11 taken along the lines 12-12.
• FIG. 13 depicts an enlarged cross-sectional plan view of the child resistant cover of FIG. 11 taken along the lines 13-13.
• FIGs. 14-16 depict perspective, right side and front elevation views, respectively, of the distal shaft portion of the safety device of FIGs. 1-9.
• FIG. 17 depicts a cross-sectional side elevation view of the distal shaft portion of FIG. 15 taken along the lines 17-17.
• FIG. 18A depicts a front perspective view of a safety device for an oral dosage form according to a second exemplary embodiment of the invention, wherein the safety device is shown in a retracted configuration whereby the oral dosage form is shielded by a child resistant cover of the safety device.
• FIG. 18B depicts a right side perspective view of the safety device of FIG. 18A, wherein the internal mechanisms of the safety device are shown in phantom lines.
• FIG. 18C depicts a front perspective view of the safety device of FIG. 18A, wherein the safety device is shown in a deployed configuration whereby the oral dosage form is exposed.
• FIGs. 1A-17 A first exemplary embodiment of a child resistant safety device for an oral dosage form comprising a medicinal agent is depicted in FIGs. 1A-17, and a second exemplary embodiment of a child resistant safety device for an oral dosage form comprising a medicinal agent is depicted in FIGs. 18A through 18C.
• Child resistant relates to special packaging that is used to reduce the risk of children ingesting dangerous items or substances.
• Packaging designated as “child resistant” is typically subject to the rigorous testing set out in the regulatory scheme of 16 C.F.R. ⁇ 1700, which provides specific protocols for performance testing with actual children, to determine whether certain packaging can be opened.
• the oral dosage form described herein may comprise, for example, a solid, or a permeable or semi-permeable matrix capable of drug elution, form.
• the oral dosage form may be, for example, a lozenge, a pill, a tablet, or other oral dosage form capable of drug delivery via the buccal or sublingual route (transmucosal), in particular, in a form that can be equipped and used with a holders or handle.
• the oral dosage form comprises at least one medicinal agent. While at least one medicinal agent is required, it is contemplated that multiple medicinal agents may also be used.
• the term "medicinal agent” refers generally to drug products.
• Such medicinal agents may include pharmaceutical ingredients, vitamins, minerals, and dietary supplements and combinations thereof.
• Pharmaceutical ingredients may include, for example, antacids, analgesics, stimulants, sleep aids, hypnotics, antipyretics,
• antimicrobials anxiolytics, laxatives, antidepressants, antidiuretics, antiflatuents, antispasmodics, anti-inflammatory, antibiotics, diuretics, anorexics, antihistamines, antiasthmatics, antidiuretics, antiflatuents, antimigraine agents, antispasmodics, sedatives, antihyperactives, antihypertensives, tranquilizers, decongestants, immunosuppressants, anticancers, antivirals, antiparasitics, antifungals, antiemetics, antidepressants, antiepileptics, local anesthetics, vasoactive agents, antiasthmatics, skeletal muscle relaxants, drugs for parkinsonism, antipsychotics, hematopoietic growth factors, antihyperlipidemics, anticoagulants, fibrinolytics, antithrombotics, hormones, therapeutic proteins and peptides, antiarrhythmia, anti
• the medicinal agent is a pharmaceutical agent having a high likelihood of abuse by people.
• the medicinal agent is a pain medication such as a narcotic or nonnarcotic analgesic, for example, as listed on pages THER-2 and THER-3 of The Merck Index, 13th Ed., Published by Merck & Co., Inc., of Whitehouse Station, N.J., copyright 2001, which is hereby incorporated by reference.
• Suitable narcotic analgesics include, for example, analgesics, pain relievers, opioids, such as, for example, oxycodone, codeine, hydrocodone, morphine,
• dexmethylphenidate, and pemoline sedative / hypnotics, such as, for example, barbiturates, such as, for example, amobarbital, aprobarbital, butabarbital, mephobarbital, phenobarbital, secobarbital; benzodiazepines, such as, for example, alprazolam, clonazepam, diazepam, estazolam, flurazepam, halazepam, lorazepam, midazolam, quazepam, temazepam, triazolam, prazepam, and oxazepam; and eugeroics, such as, for example, modafmil and armodafmil.
• Particularly suitable medicinal agents include oxycodone, fentanyl and hydromorphone. Salts of all of the medicinal agents listed above are also contemplated, as are their stereogenic isomers, polymorphs and solvates
• the medicinal agent may be administered via transmucosal or sublingual routes.
• FIGs. 1A and IB each depicts a perspective view of a child resistant safety device 10 for an oral dosage form 12.
• the child resistant safety device 10 is shown in a retracted configuration wherein the oral dosage form 12 is shielded by a child resistant cover 14.
• the child resistant safety device 10 is shown in a deployed configuration wherein the oral dosage form 12 is exposed through an opening 17 in the cover 14 for the purpose of consumption.
• the child resistant safety device 10 is capable of moving between the retracted configuration of FIG. 1A and the deployed configuration of FIG. IB by a user of the device 10.
• FIG. 2 depicts an exploded view of the safety device 10 of FIGs. 1A and IB.
• the safety device 10 generally comprises a shaft assembly 16 and a safety cover 14 that is retractably mounted to the shaft assembly 16.
• the proximal end 16a of the shaft assembly 16 is configured to be grasped by a user, and the distal end 16b of the shaft assembly 16 is configured to fixedly receive the oral dosage form 12.
• the oral dosage form 12 is not necessarily a component of the safety device 10.
• the components of the safety device 10 may be formed from any materials known to those of ordinary skill in the art, such as plastic or metal, for example.
• the spring 23 of the safety device 10 may be formed from any resilient material, such as spring steel, for example.
• the shaft assembly 16 includes a two-piece shaft, having a proximal shaft portion 18 that is fixed to a distal shaft portion 20, and a captivated plunger 21 that is loaded by a spring 23 and is capable of translation within an opening formed through the two-piece shaft.
• the proximal shaft portion 18 includes a substantially tubular body having an opening extending along its entire length such that both ends of the tubular body are open. As shown in FIG. 5, a circumferential shoulder 13 is formed on the distal end of the proximal shaft portion 18.
• the proximal end of the distal shaft portion 20 is configured to be seated on the shoulder of the proximal shaft portion 18, as best shown in FIGs. 5 and 6.
• the shaft portions 18 and 20 of the shaft assembly 16 are separate components that are fixed to each other, however, the shaft portions 18 and 20 may be combined together into a single unitary component.
• a circumferential shoulder 46 is formed on the interior surface of the proximal shaft portion 18.
• the proximal end of the spring 23 is configured to be seated on the shoulder 46 of the proximal shaft portion 18.
• a radially-inwardly extending protrusion 22 is defined on the distal end of the proximal shaft portion 18 (see FIG. 6).
• the radially-inwardly extending protrusion 22 is press-fit into a rectangular slot 24 that is defined on the exterior surface of the proximal end of the distal shaft portion 20.
• the shaft portions 18 and 20 are not readily releasable from each other.
• the opening at the proximal end 16a of the proximal shaft portion 18 is sized to accommodate the proximal end of the plunger 21 when the plunger 21 is in its fully-deployed position, as shown in FIG. 9B.
• the distal shaft portion 20 of the shaft assembly 16 includes a substantially tubular body having an opening extending along its entire length such that both ends of the tubular body are open.
• At least one guiding rib 28 extends from the outer surface of the distal shaft portion 20 in an axial direction along the longitudinal axis 'A.' The guiding ribs 28 are located toward the distal end of the distal shaft portion 20. The guiding ribs 28 are positioned on opposite sides of the distal shaft portion 20.
• the guiding ribs 28 are slidingly positioned within corresponding slots 30 (see FIGs. 2 and 13) that are defined on the interior surface of the safety cover 14.
• the guiding ribs 28 and the slots 30 help guide the shaft assembly 16 as it translates with respect to the safety cover 14, or vice versa.
• the guiding ribs 28 and the slots 30 also prevent rotation of the shaft assembly 16 with respect to the safety cover 14, or vice versa, about the longitudinal axis 'A.'
• the distal end 16b of the distal shaft portion 20 includes a necked-down portion 32.
• the post 34 of the oral dosage form 12 is fixedly positioned in the opening that passes through the necked-down portion 32.
• the post 34 of the oral dosage form 12 and the necked-down portion 32 may be fixed together by a sonic weld, an interference fit or an adhesive, for example, to prevent inadvertent detachment of the oral dosage form 12 from the safety device 10.
• At least one slot 36 is defined along the central portion of the distal shaft portion 20.
• two slots 36 are positioned opposite one another on the distal shaft portion 20.
• the slot 36 is defined through the entire thickness of the side wall of the distal shaft portion 20.
• the width ' W of the slot 36 is constant along its length.
• an opening 40 is provided at the distal end of the slot 36, and a wall 42 is provided at the proximal end of the slot 36.
• the slot 36 extends between the opening 40 and the wall 42.
• depressible and resilient tabs 44 on the cover 14 are both removably and slidably positioned with respective slots 36 on the distal shaft portion 20.
• a hole 41 is defined on the outer surface of the distal shaft portion 20 at the entrance of each slot 36, i.e., at a location that is directly distal of the opening 40 of each slot 36.
• the hole 41 accommodates translation of a respective tab 44 of the cover 14 in a radial direction toward the longitudinal axis 'A' of the safety device 10.
• the hole 41 passes through the entirety of the distal shaft portion 20.
• a plunger 21 of the shaft assembly 16 is slideably positioned within an interior chamber 49 of the shaft assembly 16.
• a resilient compression spring 23 bears on the plunger 21 and the proximal shaft portion 18. More particularly, the spring 23 is mounted between a shoulder 46 (see FIG. 6) that is formed on the interior surface of the proximal shaft portion 18 and another shoulder 48 that is formed on the exterior surface of the distal end of the plunger 21.
• the spring 23 biases the plunger 21 in the distal direction against the cover 14, thereby biasing the cover 14 toward its retracted position that is shown in FIGs. 3-6.
• the spring rate of the spring 23 is selected such that it is low enough to enable easy translation of the plunger 21 by the user, yet high enough to return the plunger 21 to its retracted position shown in FIGs. 5 and 6.
• the device 10 may incorporate a damping means to prevent the device 10 from moving between the deployed and retracted positions too rapidly.
• the damping means may be a fluid 51 (shown schematically in FIG. 5), such as a food-grade grease, that is provided in the interior chamber 49 of the shaft assembly 16.
• the device 10 may be modified by (i) mounting an O-ring (not shown) at the proximal end of the plunger 21 to contact the revolved interior surface of the shaft assembly 16, and (ii) closing at least the proximal end 16a of the shaft assembly 16.
• the damping means may also be an O-ring (not shown) that is mounted at the proximal end of the plunger 21 to contact the revolved interior surface of the shaft assembly 16.
• the O-ring would provide a friction force that opposes the force of the spring 23 as the spring 23 automatically translates the device 10 from a deployed position to a retracted position once the device 10 is released by the user.
• the damping means may also be a second spring that is mounted to the plunger 21 to bias the plunger 21 in a proximal direction.
• the spring rate of the second spring would be lower than that of the spring 23 so that the device 10 can automatically return to its retracted position once the device 10 is released by the user.
• the damping means is an optional feature of the invention and it may be omitted entirely.
• the plunger 21 is sandwiched between the spring 23 and the cover 14.
• the distal end 52 (see FIG. 2) of the plunger 21 bears on the proximal end of the cover 14.
• the proximal end of the cover 14 pushes the plunger 21 in the proximal direction against the force of the spring 23.
• the spring 23 urges the plunger 21 in a distal direction against the cover 14, thereby causing the cover 14 to also move in the distal direction.
• the child resistant cover 14 of the safety device 10 is best shown in FIGs. 1A, 2 and 10-13. Detailed views of the cover 14 are shown in FIGs. 10-13.
• the cover 14 includes a tubular body defining an opening 17 at its distal end through which the medicinal agent 12 can be exposed, and at least one resiliently moveable tab 44 that is formed on the body.
• the cover 14 is a unitary component, according to this embodiment.
• the cover 14 includes two tabs 44 that are defined on opposing sides of the body.
• the structure and function of only one of the tabs 44 will be described hereinafter, however, it should be understood that the structure and function of both tabs 44 are the same.
• the tab 44 of the safety cover 14 interacts with the slot 36 that is formed on the shaft assembly 16 to releasably lock the safety device 10 in the retracted position.
• the tab 44 may also be referred to herein as a releasable locking mechanism.
• the tab 44 is configured to "child resistant" the device 10 because the tab 44 must be depressed inwardly toward the longitudinal axis 'A' (see FIG. 12) before the cover 14 can be translated with respect to the shaft assembly 16 (or vice versa) to expose the medicinal agent 12.
• the tab 44 includes an outer surface 56 that is capable of being contacted by the finger of a user, a relatively narrow rib 58 depending from the outer surface 56 that extends in a radial direction toward the longitudinal axis ⁇ ,' and a wide stop 60 that is defined on the end of the narrow rib 58.
• the width 'Wl ' of the rib 58 is less than the width ' W (see FIG. 4) of the slot 36, whereas the width 'W2' of the stop 60 is greater than the width ' W of the slot 36. Accordingly, in the assembled form of the device 10, the rib is 58 capable of translating in the slot 36, whereas the stop 60 is not able to be positioned within the slot 36.
• the stop 60 In the retracted position of the device 10, the stop 60 is registered with the opening 40 of the slot 36. This is referred to herein as the locked configuration of the tab 44.
• the stop 60 abuts against a bearing surface 54 at the distal end 16b of the shaft assembly 16 because the width 'W2' of the stop 60 is greater than the width ' W of the opening 40 of the slot 36. Thus, the stop 60 can not pass through the opening 40.
• the abutment between the stop 60 and the opening 40 prevents the cover 14 from translating in a proximal direction with respect to the shaft assembly 16, and prevents the shaft assembly 16 from translating in a proximal direction with respect to the cover 14.
• the cover 14 in a retracted position of the device 10, the cover 14 is incapable of translating with respect to the shaft assembly 16 (and vice versa), thereby preventing access to the medicinal agent 12 that is contained within the interior of the cover 14.
• the narrow rib 58 In the retracted position of the device, the narrow rib 58 does not register with the slot 36, as shown in FIG. 6.
• FIGS. 6, 7B, 8B and 9B depict successive movement of the safety device from a retracted position to the deployed position.
• the safety device 10 is ordinarily stored in the retracted position that is shown in FIG. 6.
• the cover 14 can not be translated with respect to the shaft assembly 16 (and vice versa) because the stop 60 of the tab 44 is lodged in the hole 41 of the distal shaft portion 20 and is sandwiched between the opening 40 of the slot 36 and the surface 70 (see FIG. 6 and 17).
• the stop 60 is wider than the opening 40, and thus can not enter the opening 40.
• FIG. 7B depicts the depressed position of the tab 44. Depressing the tab 44 towards the
• longitudinal axis 'A' registers the rib 58 of the tab 44 with the opening 40 of the slot 36, and moves the stop 60 into the hole 41 that is formed on the distal shaft portion 20.
• the width of the rib 58 is less than the width of the slot 36, thus, the rib 58 can translate along the slot 36.
• FIGs. 7B, 8B and 9B depict the sequential movement of the safety device 10 from a retracted position to the deployed position.
• the cover 14 can be translated in the proximal direction while the shaft assembly 16 remains stationary.
• the shaft assembly 16 can be translated in a distal direction while the cover 14 remains stationary.
• the cover 14 can be translated in the proximal direction while the shaft assembly 16 is translated in a distal direction. Any of the aforementioned translational movements will produce the same result, i.e., the safety device 10 will be moved to the deployed position of FIG. 9B.
• the description that follows assumes that the cover 14 is translated in the proximal direction while the shaft assembly 16 remains stationary.
• the rib 58 of the tab 44 is registered with the opening 40 of the slot 36. Thereafter, the cover 14 is translated in a proximal direction along the longitudinal axis 'A' against the force of the spring 23 while the shaft assembly 16 remains stationary. As the cover 14 is translated in the proximal direction toward the position shown in FIG. 8B, the rib 58 slides in the slot 36 while the stop 60 of the tab 44 rides along the revolved interior surface of the distal shaft portion 20. At this point, the tab 44 can be released by the user. Upon releasing the tab 44, the rib 58 remains in the slot 36 while the stop 60 continues to bear on the revolved interior surface of the distal shaft portion 20. The stop 60 does not prevent translation of the cover 14 once the stop 60 is positioned against the revolved interior surface of the distal shaft portion 20.
• the proximal end of the stop 60 bears on the distal end surface 52 of the plunger 21 thereby urging the plunger 21 in the proximal direction against the force of the spring 23.
• the cover 14 is translated against the force of the spring 23.
• the spring 23 is compressed between the plunger 21 and the proximal shaft portion 18 as the user translates the cover 14 in the proximal direction.
• the user translates the cover 14 in a proximal direction along the longitudinal axis 'A' until the rib 58 contacts the end wall 42 of the slot 36 at which point the cover 14 is prevented from moving further in the proximal direction.
• the device 10 is in the deployed position that is shown in FIG. 9B. In the deployed position of the device 10, the cover 14 is spaced from the medicinal agent 12 and the medicinal agent 12 is exposed and available to the user.
• the device 10 includes a damping agent 51 (see FIG. 5), the damping agent 51 would slow the return of the cover 14 to the retracted position. Once the cover 14 returns to its retracted position, the resilient tab 44 moves outward and away from the longitudinal axis 'A' and returns to its position shown in FIG. 6. Thereafter, the device 10 may be moved back to the deployed position, as previously described, if so desired.
• FIGs. 18A-18C depict another safety device 100 for a medicinal agent, according to a second exemplary embodiment of the invention.
• the safety device 100 generally includes a hollow cylindrical tube 101 defining an opening 103, a spring-loaded shaft 108 that is moveably positioned within the interior of the tube 101, a medicinal agent 102 that is fixedly attached to a distal end of the shaft 108, and a child resistant lever 104 that is fixedly attached to a proximal end of the spring-loaded shaft 108.
• the child resistant lever 104 is provided for moving the shaft 108 and the medicinal agent 102 between the retracted position of FIGs. 18A and 18B and the deployed position of FIG. 18C.
• the user In a retracted position of the device 100, the user is unable to consume the medicinal agent 102, whereas, in the deployed position of the device 100, the medicinal agent 102 is available to the user for consumption.
• a spring 106 is positioned around the shaft 108 between an interior shoulder 110 of the tube 101 and a leg 105 extending from the lever 104.
• the leg 105 is fixedly connected between the lever 104 and the proximal end of the shaft 108.
• the spring 106 is positioned to bias the lever 104, the shaft 108 and the medicinal agent 102 in a downward direction (as viewed in FIGs. 18A-18C) toward the retracted position shown in FIG. 18B.
• a ramp 114 is formed on the outer surface of the tube 101. In operation, a user must pull the lever 104 away from the tube 101 to clear the ramp 114 before advancing the lever 104 (along with the medicinal agent 102 that is indirectly attached to the lever 104) in an upward direction toward the deployed position shown in FIG.
• the spring 106 automatically urges the lever 104, the shaft 108 and the medicinal agent 102 in a downward direction to the retracted position shown in FIG. 14B.
• the force of the spring 106 is sufficient to move the lever 104 in the downward direction along the angled surface of the ramp 114.
• the lever 104 ultimately comes to rest in the position shown in FIG. 18B.
• the ramp 114 serves as the child resistant feature of the device 100. Those of ordinary skill in the art will recognize that other ways exist to child resistant the device 100.

Landscapes

• Health & Medical Sciences (AREA)
• Veterinary Medicine (AREA)
• Life Sciences & Earth Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• General Health & Medical Sciences (AREA)
• Public Health (AREA)
• Pharmacology & Pharmacy (AREA)
• Chemical & Material Sciences (AREA)
• Medicinal Chemistry (AREA)
• Epidemiology (AREA)
• Engineering & Computer Science (AREA)
• Emergency Medicine (AREA)
• Mechanical Engineering (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Biomedical Technology (AREA)
• Neurology (AREA)
• Neurosurgery (AREA)
• Pain & Pain Management (AREA)
• General Chemical & Material Sciences (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Organic Chemistry (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Infusion, Injection, And Reservoir Apparatuses (AREA)
• Medical Preparation Storing Or Oral Administration Devices (AREA)
• Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Priority Applications (7)

Applications Claiming Priority (2)

Related Child Applications (1)

Publications (1)

Family

ID=50442704

Family Applications (1)

Country Status (8)

Families Citing this family (2)

Citations (5)

Family Cites Families (6)

• 2014
  • 2014-03-13 JP JP2016501858A patent/JP2016513537A/ja active Pending
  • 2014-03-13 MX MX2015011634A patent/MX2015011634A/es unknown
  • 2014-03-13 EP EP14716160.8A patent/EP2968072B1/en active Active
  • 2014-03-13 HK HK16106615.4A patent/HK1218617A1/zh unknown
  • 2014-03-13 WO PCT/US2014/025483 patent/WO2014159934A1/en not_active Ceased
  • 2014-03-13 CA CA2903828A patent/CA2903828A1/en not_active Abandoned
• 2015
  • 2015-09-03 IL IL241088A patent/IL241088A0/en not_active IP Right Cessation
  • 2015-09-10 US US14/849,719 patent/US20160001957A1/en not_active Abandoned

Patent Citations (5)

Non-Patent Citations (1)

Also Published As

Similar Documents

Legal Events